Showing results (1331-1340 of 6,572) with videos related to

Sort By:
Pageof 658
Clinical, Cosmetic and Investigational Dermatology|July 15, 2022
Koji amazake Maintains Water Content in the Left Cheek Skin of Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Comparative TrialToshihiko Enomoto, Ayana Kojima-Nakamura, Kazuya Kodaira, et al.
Thyroid : Official Journal of the American Thyroid Association|October 20, 1998
Thyrocyte class I and class II upregulation is a secondary phenomenon and does not contribute to the pathogenesis of autoimmune thyroid diseaseS J Yue, T Enomoto, Y Matsumoto, et al.
Journal of Food Protection|April 7, 2009
Combination treatments for killing Escherichia coli O157:H7 on alfalfa, radish, broccoli, and mung bean seedsM L Bari, D Nei, K Enomoto, et al.
The American Journal of Pathology|April 12, 2015
Heparanase stimulates chondrogenesis and is up-regulated in human ectopic cartilage: a mechanism possibly involved in hereditary multiple exostosesJulianne Huegel, Motomi Enomoto-Iwamoto, Federica Sgariglia, et al.
Analytical and Bioanalytical Chemistry|March 2, 2011
Authenticity assessment of beef origin by principal component analysis of matrix-assisted laser desorption/ionization mass spectrometric dataNobuhiro Zaima, Naoko Goto-Inoue, Takahiro Hayasaka, et al.
Plastic and Reconstructive Surgery|September 8, 2001
Prefabricated vascularized bone flap: a tissue transformation technique for bone reconstructionM I Alam, I Asahina, I Seto, et al.
Oral Oncology|February 13, 2001
Expression of heparanase in oral cancer cell lines and oral cancer tissuesM Ikuta, K A Podyma, K Maruyama, et al.
Journal of Bacteriology|July 3, 2025
Beyond movement: the dynamic roles of Type IV pili in cyanobacterial lifeJonas Hammerl, Nils Schuergers, Gen Enomoto, et al.
Neuropsychopharmacology Reports|November 24, 2022
Preliminary analysis of hippocampus synaptic apoptosis and microglial phagocytosis induced by severe restraint stressShingo Enomoto, Masahiro Ohgidani, Noriaki Sagata, et al.
Pain Medicine (Malden, Mass.)|March 12, 2019
An Open-Label, 52-Week, Phase III Trial of Duloxetine in Japanese Patients with Chronic Low Back PainShin-Ichi Konno, Levent Alev, Natsuko Oda, et al.
Pageof 658